SCHEMBL733252

SCHEMBL733252

CNc1ncnc2c1ncn2Cc1nc2cccc(C)c2c(=O)n1-c1ccc(C)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 12/20 0.68
PIK3R1 P27986 4/20 0.68
PIK3CB P42338 5/20 0.60
PIK3CG P48736 5/20 0.60
PDE4A P27815 3/20 0.45
PDE4B Q07343 3/20 0.45
PDE4C Q08493 3/20 0.45
PDE4D Q08499 3/20 0.45
PDE5A O76074 2/20 0.44
PDE1A P54750 2/20 0.44
PDE1B Q01064 2/20 0.44
PDE3B Q13370 2/20 0.44
PDE1C Q14123 2/20 0.44
PDE3A Q14432 2/20 0.44
GAA P10253 1/20 0.41
YTHDC1 Q96MU7 1/20 0.40
PIK3CA P42336 3/20 0.39
ABL1 P00519 1/20 0.38
SRC P12931 1/20 0.38
MTOR P42345 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733251 0.88 PIK3CD (0.77) PIK3CDPIK3R1PIK3CBPIK3CGPDE4A
SCHEMBL3398713 0.88 PIK3CD (0.67) PIK3CDPIK3R1PIK3CBPIK3CGPDE4A
SCHEMBL733537 0.86 PIK3CD (0.68) PIK3CDPIK3R1PIK3CBPIK3CGGAA
SCHEMBL3399490 0.79 PIK3CD (0.64) PIK3CDPIK3R1PIK3CBPIK3CGGAA
SCHEMBL17185514 0.79 PIK3CD (0.73) PIK3CDPIK3R1PIK3CBPIK3CGPIK3CA
SCHEMBL4160767 0.79 PIK3CD (0.73) PIK3CDPIK3R1PIK3CBPIK3CGPIK3CA
SCHEMBL734026 0.78 PIK3CD (0.71) PIK3CDPIK3R1PIK3CBPIK3CGPIK3CA
SCHEMBL4149819 0.75 PIK3CD (0.54) PIK3CDPIK3R1PIK3CBPIK3CGGAA
SCHEMBL360745 0.75 PIK3CD (1.00) PIK3CDPIK3R1PIK3CBPIK3CGPIK3CA
SCHEMBL29358478 0.75 PIK3CD (1.00) PIK3CDPIK3R1PIK3CBPIK3CGPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138195-B2 Inhibitors of human phosphatidylinositol 3-kinase delta ICOS CORPORATION (US) 2012-03-20 US disclosed
US-20050261317-A1 Inhibitors of human phosphatidylinositol 3-kinase delta ICOS CORPORATION (US) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261317-A1 Inhibitors of human phosphatidylinositol 3-kinase delta PIK3CD, PIK3R5, PIK3CA PIK3CD 1/4885PIK3R1 20/4885PIK3CB 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.